Published in
Elsevier, EClinicalMedicine, (63), p. 102130, 2023
DOI: 10.1016/j.eclinm.2023.102130
Links
Tools
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
Journal article published in 2023 by
Marek Trněný,
Abraham Avigdor,
Matthew S. McKinney,
Shankara Paneesha 
,
Björn E. Wahlin,
John S. Hrom,
David Cunningham ,
Nicholas Morley,
Miguel Canales,
Mariana Bastos-Oreiro,
David Belada,
Liliana Devizzi,
Fred Zheng,
Douglas J. DeMarini,
Wei Jiang
and other authors.
,
Björn E. Wahlin,
John S. Hrom,
David Cunningham ,
Nicholas Morley,
Miguel Canales,
Mariana Bastos-Oreiro,
David Belada,
Liliana Devizzi,
Fred Zheng,
Douglas J. DeMarini,
Wei Jiang
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 